280 related articles for article (PubMed ID: 37536019)
1. Molecular profile of non-coding RNA-mediated glycolysis control in human cancers.
Mirzaei S; Ranjbar B; Tackallou SH
Pathol Res Pract; 2023 Aug; 248():154708. PubMed ID: 37536019
[TBL] [Abstract][Full Text] [Related]
2. Emerging Role of Non-Coding RNAs in Esophageal Squamous Cell Carcinoma.
Feng Q; Zhang H; Yao D; Chen WD; Wang YD
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905958
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis?
Mirzaei S; Zarrabi A; Hashemi F; Zabolian A; Saleki H; Ranjbar A; Seyed Saleh SH; Bagherian M; Sharifzadeh SO; Hushmandi K; Liskova A; Kubatka P; Makvandi P; Tergaonkar V; Kumar AP; Ashrafizadeh M; Sethi G
Cancer Lett; 2021 Jul; 509():63-80. PubMed ID: 33838282
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response.
Sadrkhanloo M; Entezari M; Rashidi M; Hashemi M; Raesi R; Saghari S; Daneshi S; Salimimoghadam S; Hushmandi K; Mirzaei S; Taheriazam A
Eur J Pharmacol; 2022 Oct; 932():175212. PubMed ID: 36055365
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications.
Zhang Y; Zhan L; Jiang X; Tang X
Biochem Pharmacol; 2024 Jun; 224():116218. PubMed ID: 38643906
[TBL] [Abstract][Full Text] [Related]
6. Noncoding RNA crosstalk in brain health and diseases.
Mehta SL; Chokkalla AK; Vemuganti R
Neurochem Int; 2021 Oct; 149():105139. PubMed ID: 34280469
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNA-based therapeutics in cancer therapy: An emphasis on Wnt/β-catenin control.
Taheriazam A; Bayanzadeh SD; Heydari Farahani M; Mojtabavi S; Zandieh MA; Gholami S; Heydargoy MH; Jamali Hondori M; Kangarloo Z; Behroozaghdam M; Khorrami R; Sheikh Beig Goharrizi MA; Salimimoghadam S; Rashidi M; Hushmandi K; Entezari M; Hashemi M
Eur J Pharmacol; 2023 Jul; 951():175781. PubMed ID: 37179043
[TBL] [Abstract][Full Text] [Related]
8. Non-coding RNAs and macrophage interaction in tumor progression.
Entezari M; Sadrkhanloo M; Rashidi M; Asnaf SE; Taheriazam A; Hashemi M; Ashrafizadeh M; Zarrabi A; Rabiee N; Hushmandi K; Mirzaei S; Sethi G
Crit Rev Oncol Hematol; 2022 May; 173():103680. PubMed ID: 35405273
[TBL] [Abstract][Full Text] [Related]
9. Role of hedgehog signaling related non-coding RNAs in developmental and pathological conditions.
HajiEsmailPoor Z; Tabnak P; Ahmadzadeh B; Ebrahimi SS; Faal B; Mashatan N
Biomed Pharmacother; 2022 Sep; 153():113507. PubMed ID: 36076513
[TBL] [Abstract][Full Text] [Related]
10. ncRNADrug: a database for validated and predicted ncRNAs associated with drug resistance and targeted by drugs.
Cao X; Zhou X; Hou F; Huang YE; Yuan M; Long M; Chen S; Lei W; Zhu J; Chen J; Zhang T; Guo AY; Jiang W
Nucleic Acids Res; 2024 Jan; 52(D1):D1393-D1399. PubMed ID: 37953323
[TBL] [Abstract][Full Text] [Related]
11. Targeting non-coding RNAs to overcome cancer therapy resistance.
Chen B; Dragomir MP; Yang C; Li Q; Horst D; Calin GA
Signal Transduct Target Ther; 2022 Apr; 7(1):121. PubMed ID: 35418578
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis in human cancers: Emphasis circRNA/glycolysis axis and nanoparticles in glycolysis regulation in cancer therapy.
Alkhathami AG; Sahib AS; Al Fayi MS; Fadhil AA; Jawad MA; Shafik SA; Sultan SJ; Almulla AF; Shen M
Environ Res; 2023 Oct; 234():116007. PubMed ID: 37119844
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways.
Hashemi M; Roshanzamir SM; Paskeh MDA; Karimian SS; Mahdavi MS; Kheirabad SK; Naeemi S; Taheriazam A; Salimimoghaddam S; Entezari M; Mirzaei S; Samarghandian S
Eur J Pharmacol; 2023 Feb; 941():175380. PubMed ID: 36627099
[TBL] [Abstract][Full Text] [Related]
14. Non-coding RNA-based regulation of inflammation.
Ashrafizadeh M; Zarrabi A; Mostafavi E; Aref AR; Sethi G; Wang L; Tergaonkar V
Semin Immunol; 2022 Jan; 59():101606. PubMed ID: 35691882
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.
Xia M; Feng S; Chen Z; Wen G; Zu X; Zhong J
Life Sci; 2020 Jun; 250():117579. PubMed ID: 32209425
[TBL] [Abstract][Full Text] [Related]
16. The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.
Shi T; Zhang C; Xia S
Mol Cell Biochem; 2022 May; 477(5):1371-1380. PubMed ID: 35142950
[TBL] [Abstract][Full Text] [Related]
17. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
[TBL] [Abstract][Full Text] [Related]
18. Role of noncoding RNAs and untranslated regions in cancer: A review.
Zhang Y; Yang M; Yang S; Hong F
Medicine (Baltimore); 2022 Aug; 101(33):e30045. PubMed ID: 35984196
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNA dysregulation in skin cancers.
Durante G; Comito F; Lambertini M; Broseghini E; Dika E; Ferracin M
Essays Biochem; 2021 Oct; 65(4):641-655. PubMed ID: 34414406
[TBL] [Abstract][Full Text] [Related]
20. Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironment.
Xu Z; Chen Y; Ma L; Chen Y; Liu J; Guo Y; Yu T; Zhang L; Zhu L; Shu Y
Mol Ther; 2022 Oct; 30(10):3133-3154. PubMed ID: 35405312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
